Susan's Place Logo

News:

Since its founding in 1995 Susan's Place forums have blossomed into a truly global lifeline. To date we've delivered roughly 1.4 billion page views to hundreds of millions of unique visitors, guided more than 41,000 registered members through 1,985,081 posts and 188,474 topics across 193 boards, and—most importantly—helped save tens of thousands of lives by connecting people to vital information and support at their most vulnerable moments.

Main Menu

Combo Treatment Helps Fight Early Breast Cancer

Started by LostInTime, November 03, 2006, 10:18:35 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Print
Go Down Pages1
User actions

LostInTime

November 03, 2006, 10:18:35 AM
Article

As reported in the Nov. 2 New England Journal of Medicine, an analysis of two trials shows that the addition of epirubicin provides a 30 percent reduction in the risk of relapse and death, said lead researcher Dr. Christopher J. Poole, Macmillan Senior Lecturer in Medical Oncology at the University of Birmingham.

The study is expected to have more of an impact in Europe and elsewhere, since epirubicin is more commonly used overseas than in the United States or Canada, said Dr. Mark Levine, a professor of clinical epidemiology and biostatistics and oncology at McMaster University in Hamilton, Ontario.
  •  
Print
Go Up Pages1
User actions